-
1 Comment
Jinxin Fertility Group Limited is currently in a long term uptrend where the price is trading 8.8% above its 200 day moving average.
From a valuation standpoint, the stock is 77.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 25.5.
Jinxin Fertility Group Limited's total revenue sank by 5.0% to $814M since the same quarter in the previous year.
Its net income has dropped by 43.4% to $136M since the same quarter in the previous year.
Finally, its free cash flow grew by 152.7% to $104M since the same quarter in the previous year.
Based on the above factors, Jinxin Fertility Group Limited gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Care Facilities |
| Exchange | HK |
| CurrencyCode | HKD |
| ISIN | KYG5140J1013 |
| Market Cap | 8B |
|---|---|
| Dividend Yield | 2.0% |
| Beta | 1.45 |
| PE Ratio | 26.0 |
| Target Price | 3.8915 |
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; obstetrics, gynecology, urology, internal medicine, and pediatrics medical services; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, postpartum and rehabilitation care, property investment, and real estate development and operation activities. Additionally, the company is involved in the sale of medicines, consumables, and equipment; and research and development of IVF related projects, including scientific research and related commercialization. Jinxin Fertility Group Limited was founded in 1951 and is headquartered in Chengdu, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1951.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
